CU Medicine Medical Oncology
Highlands Ranch Specialty Care Center1500 Park Central Drive, Suite 101, Highlands Ranch, CO 80129
UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus12605 E. 16th Ave Aurora, CO 80045
UCHealth Blood Disorders and Cell Therapies Center - Anschutz Medical Campus1665 Aurora Court 3rd floor, Anschutz Cancer Pavilion, Aurora, CO 80045
I believe in providing optimal care for lymphoma patients, that is based on an integration of research-based evidence, clinical competence, and the patient values and preferences.
- Internal Medicine
Conditions & Treatments
Blood / Lymphatic System
Interests & Activities
Following completion of medical school in Kurdistan Region of Iraq, Dr. Jasem came to the United States as a Fulbright Scholar and pursued a master's degree in public health/epidemiology at the University of Nebraska Medical Center. Meanwhile, he re-qualified his medical degree and conducted research, both locally and internationally, involving the health needs assessment of the underserved and refugee populations. He later pursued an internship in internal medicine at The Ohio State University, residency in internal medicine at the University of Colorado, and fellowship in hematology at Johns Hopkins University. In his free time, Dr. Jasem enjoys hiking, soccer, listening to classic oriental music; and translating and publishing history, political, and scientific books from English to Arabic and Kurdish.
Education & Training
MPH, University of Nebraska Medical Center (2012)
Ohio State University Hospital Program (2014)
University of Colorado (2016)
Johns Hopkins University School of Medicine Program (2020)
American Medical Informatics Association (AMIA), Member
American Public Health Association, Member
American Society of Clinical Oncology, Member
American Society of Hematology, Member
Society of General Internal Medicine, Member
Research & Grants
Research Interests for Patients
My research interests involve evaluating the health outcomes of patients with lymphoma and other hematological malignancies; including assessing survivorship patterns, quality of care delivered, disparities in care, and the economic burden of cancer care delivery.